A Negative (1,3)-β-D-Glucan Result Alone Is Not Sufficient to Rule Out a Diagnosis of Pneumocystis Pneumonia in Patients With Hematological Malignancies

Assessment of the Role of 1,3-β-d-Glucan Testing for the Diagnosis of Invasive Fungal Infections in Adults

(2021) F Lamoth et al.   CLINICAL INFECTIOUS DISEASES

Pneumocystis Pneumonia: Immunity, Vaccines, and Treatments

(2021) Aaron D. Gingerich et al.   Pathogens

Diagnostic accuracy of the 1,3-beta-d-glucan test and lactate dehydrogenase for pneumocystis pneumonia in non-HIV patients

(2021) Ruixue Sun et al.   Scientific Reports

Pneumocystis jiroveci

(2020) Jay A. Fishman   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE

Diagnostic accuracy of serum (1-3)-β-D-Glucan for Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis

(2020) Olivier Del Corpo et al.   CLINICAL MICROBIOLOGY AND INFECTION

Epidemiology of Pneumocystis jirovecii Pneumonia and (Non-)use of Prophylaxis

(2020) Albert Dunbar et al.   Frontiers in Cellular and Infection Microbiology

Serum (1,3)-Beta-d-Glucan has suboptimal performance for the diagnosis of Pneumocystis jirovecii pneumonia in cancer patients and correlates poorly with respiratory burden as measured by quantitative PCR

(2020) Ariel D. Szvalb et al.   JOURNAL OF INFECTION

Diagnostic evaluation of serum (1, 3)-β-d-glucan levels using the Fungitec G-Test MK kit for Pneumocystis jirovecii pneumonia (PCP) in non-HIV patients

(2020) Shuhei Ideguchi et al.   MEDICAL MYCOLOGY

Clinical evaluation of two different (1,3)‐ß‐ d ‐glucan assays for diagnosis of invasive fungal diseases: A retrospective cohort study

(2020) Marta Zubkowicz et al.   MYCOSES

Variable Correlation between Bronchoalveolar Lavage Fluid Fungal Load and Serum-(1,3)-β-d-Glucan in Patients with Pneumocystosis—A Multicenter ECMM Excellence Center Study

(2020) Toine Mercier et al.   Journal of Fungi

Specificity Influences in (1→3)-β-d-Glucan-Supported Diagnosis of Invasive Fungal Disease

(2020) Malcolm A. Finkelman   Journal of Fungi

Pneumocystis jirovecii Disease: Basis for the Revised EORTC/MSGERC Invasive Fungal Disease Definitions in Individuals Without Human Immunodeficiency Virus

(2020) Katrien Lagrou et al.   CLINICAL INFECTIOUS DISEASES

Molecular diagnosis of Pneumocystis pneumonia in immunocompromised patients

(2019) Hélène Guegan et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Serum-based diagnosis of Pneumocystis pneumonia by detection of Pneumocystis jirovecii DNA and 1,3-β-D-glucan in HIV-infected patients: a retrospective case control study

(2019) Helena Hammarström et al.   BMC INFECTIOUS DISEASES

Diagnosis and treatment of Pneumocystis jirovecii pneumonia in HIV-infected or non-HIV-infected patients—difficulties in diagnosis and adverse effects of trimethoprim-sulfamethoxazole

(2019) Hideaki Kato et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Point-Counterpoint: Should serum β-D- glucan testing be used for the diagnosis of Pneumocystis jiroveci pneumonia?

(2019) Gabriela Corsi-Vasquez et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Evaluation of a Turbidimetric β-D-Glucan Test for Detection of Pneumocystis jirovecii Pneumonia

(2018) Karl Dichtl et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Clinical, Diagnostic, and Treatment Disparities between HIV-Infected and Non-HIV-Infected Immunocompromised Patients with Pneumocystis jirovecii Pneumonia

(2018) Helmut J.F. Salzer et al.   RESPIRATION

Clinical Performance of (1,3) Beta-D-Glucan for the diagnosis of Pneumocystis Pneumonia in cancer patients tested with PCP PCR

(2018) Sejal Morjaria et al.   CLINICAL INFECTIOUS DISEASES

Diagnostic accuracy of the 1,3-β-D-glucan test for pneumocystis pneumonia in a tertiary university hospital in Denmark: A retrospective study

(2018) Anne Line Engsbro et al.   MEDICAL MYCOLOGY

Use of 1,3-β-D-glucan in invasive fungal diseases in hematology patients

(2017) Daniele Roberto Giacobbe et al.   Expert Review of Anti-Infective Therapy

Diagnosis and management of Pneumocystis jirovecii infection

(2017) P. Lewis White et al.   Expert Review of Anti-Infective Therapy

Usefulness of 1,3 Beta-d-Glucan Detection in non-HIV Immunocompromised Mechanical Ventilated Critically Ill Patients with ARDS and Suspected Pneumocystis jirovecii Pneumonia

(2017) Tobias Lahmer et al.   MYCOPATHOLOGIA

ECIL guidelines for the diagnosis ofPneumocystis jiroveciipneumonia in patients with haematological malignancies and stem cell transplant recipients

(2016) Alexandre Alanio et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Diagnosis of Pneumocystis pneumonia: evaluation of four serologic biomarkers

(2015) F. Esteves et al.   CLINICAL MICROBIOLOGY AND INFECTION

Update on pulmonary Pneumocystis jirovecii infection in non-HIV patients

(2014) A. Roux et al.   MEDECINE ET MALADIES INFECTIEUSES

Combined Quantification of Pulmonary Pneumocystis jirovecii DNA and Serum (1->3)- -D-Glucan for Differential Diagnosis of Pneumocystis Pneumonia and Pneumocystis Colonization

(2013) C. Damiani et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Test performance of blood beta-glucan for Pneumocystis jirovecii pneumonia in patients with AIDS and respiratory symptoms

(2012) Brian R. Wood et al.   AIDS

Clinical characteristics of Pneumocystis pneumonia in non-HIV patients and prognostic factors including microbiological genotypes

(2011) Yasufumi Matsumura et al.   BMC INFECTIOUS DISEASES

Blood (1->3)- -D-Glucan as a Diagnostic Test for HIV-Related Pneumocystis jirovecii Pneumonia

(2011) P. E. Sax et al.   CLINICAL INFECTIOUS DISEASES

 -Glucan Antigenemia Assay for the Diagnosis of Invasive Fungal Infections in Patients With Hematological Malignancies: A Systematic Review and Meta-Analysis of Cohort Studies From the Third European Conference on Infections in Leukemia (ECIL-3)

(2011) F. Lamoth et al.   CLINICAL INFECTIOUS DISEASES

Accuracy of β -D-glucan for the diagnosis of Pneumocystis jirovecii pneumonia: a meta-analysis

(2011) D.E. Karageorgopoulos et al.   CLINICAL MICROBIOLOGY AND INFECTION

Serum (1->3)- -D-Glucan Levels in Primary Infection and Pulmonary Colonization with Pneumocystis jirovecii

(2011) C. Damiani et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Diagnostic Accuracy of Serum 1,3-β-d-Glucan for Pneumocystis jiroveci Pneumonia, Invasive Candidiasis, and Invasive Aspergillosis: Systematic Review and Meta-Analysis

(2011) Akira Onishi et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Cost-Effectiveness Analysis of Diagnostic Options for Pneumocystis Pneumonia (PCP)

(2011) Julie R. Harris et al.   PLoS One

Serum (1 → 3)-β-d-glucan measurement as an early indicator of Pneumocystis jirovecii pneumonia and evaluation of its prognostic value

(2010) J. Held et al.   CLINICAL MICROBIOLOGY AND INFECTION

β-d-Glucan and S-adenosylmethionine serum levels for the diagnosis of Pneumocystis pneumonia in HIV-negative Patients: A prospective study

(2010) Mark G.J. de Boer et al.   JOURNAL OF INFECTION

Clinical Utility of Serum β-D-Glucan and KL-6 Levels in Pneumocystis jirovecii Pneumonia

(2009) Hideta Nakamura et al.   INTERNAL MEDICINE

Serum (1-3)- -D-Glucan as a Tool for Diagnosis of Pneumocystis jirovecii Pneumonia in Patients with Human Immunodeficiency Virus Infection or Hematological Malignancy

(2009) S. Desmet et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Use of a Serum β‐Glucan Assay for Diagnosis of HIV‐RelatedPneumocystis jiroveciPneumonia in Patients with Negative Microscopic Examination Results

(2008) Mary L. Pisculli et al.   CLINICAL INFECTIOUS DISEASES